CVS Health (NYSE: CVS) reported Q1 EPS of $2.22, $0.07 better than the analyst estimate of $2.15. Revenue for the quarter came in at $76.8 billion versus the consensus estimate of $75.39 billion.

GUIDANCE:

CVS Health sees FY2022 EPS of $8.20-$8.40, versus the consensus of $8.27.

For earnings history and earnings-related data on CVS Health (CVS) click here.